A dopamine/noradrenaline reuptake inhibitor improves performance in the heat, but only at the maximum therapeutic dose.
about
Neurophysiological Determinants of Theoretical Concepts and Mechanisms Involved in PacingNeurophysiological effects of exercise in the heatDopamine signaling in C. elegans is mediated in part by HLH-17-dependent regulation of extracellular dopamine levels.Exercise outcomes in prevalent users of stimulant medications.Exercise-Induced Fatigue and Caffeine Supplementation Affect Psychomotor Performance but Not Covert Visuo-Spatial AttentionThe paroxetine effect on exercise performance depends on the aerobic capacity of exercising individualsPerformance in the heat-physiological factors of importance for hyperthermia-induced fatigue.The Governor has a sweet tooth - mouth sensing of nutrients to enhance sports performance.Role of Ratings of Perceived Exertion during Self-Paced Exercise: What are We Actually Measuring?The sports psychiatrist and psychiatric medication.Fatigue: Is it all neurochemistry?Fatigue-related impairments in oculomotor control are prevented by norepinephrine-dopamine reuptake inhibition.Dopamine/noradrenaline reuptake inhibition in women improves endurance exercise performance in the heat.Oral L-menthol reduces thermal sensation, increases work-rate and extends time to exhaustion, in the heat at a fixed rating of perceived exertion.Caffeine increases the velocity of rapid eye movements in unfatigued humans.Mouth rinsing with a carbohydrate solution does not influence cycle time trial performance in the heat.The Effects of Acute Exercise on Mood, Cognition, Neurophysiology, and Neurochemical Pathways: A Review.
P2860
Q22252564-0A0F9030-5848-4F16-8031-3D1C968B4CF4Q28261589-6BCC8933-1EE3-4E29-B694-3250B8531188Q33784944-76C95264-C075-42A6-94F5-8192B42E459FQ35624268-C9C2564F-3815-45AE-924A-CADC66A71B23Q36170864-135FA35E-DFA7-4360-AE4E-60FBF324CF90Q37709258-1663BF12-CC5E-4A79-A302-654E0AFB3105Q38203225-CD4C813B-428B-4BFC-BACE-8B12AD007334Q38262800-18C3B872-B319-4245-AFBD-87A644BF550DQ38520678-0A671C3A-47E9-4102-BDF8-E9C519E046A1Q38872618-712D842E-5DC5-4905-8145-4CD4CA53998EQ39186939-71EEED61-8493-45B1-B055-6A95C0883AEAQ41788244-CC50ACE2-8513-4393-9D7D-1D3264FFE629Q47981720-753143CB-214E-4A99-8E7C-9A0054EFDCF3Q48140553-245362A7-ACB8-4198-8DE5-68AA6001270FQ52093948-F883F860-E2F8-47C2-AEB4-6DF300648812Q54264688-FFD59EC2-0240-4B5E-8345-815091B46E24Q55261025-16AE9F1A-8ABC-4218-BF31-F2B5675AD1E9
P2860
A dopamine/noradrenaline reuptake inhibitor improves performance in the heat, but only at the maximum therapeutic dose.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
A dopamine/noradrenaline reupt ...... the maximum therapeutic dose.
@en
A dopamine/noradrenaline reupt ...... the maximum therapeutic dose.
@nl
type
label
A dopamine/noradrenaline reupt ...... the maximum therapeutic dose.
@en
A dopamine/noradrenaline reupt ...... the maximum therapeutic dose.
@nl
prefLabel
A dopamine/noradrenaline reupt ...... the maximum therapeutic dose.
@en
A dopamine/noradrenaline reupt ...... the maximum therapeutic dose.
@nl
P2093
P2860
P1476
A dopamine/noradrenaline reupt ...... the maximum therapeutic dose.
@en
P2093
B Roelands
S Decoster
P2860
P356
10.1111/J.1600-0838.2012.01502.X
P577
2012-07-30T00:00:00Z